Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale
      Health

      Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale

      November 14, 2026
      Weekly Gains Hold Up Despite a Friday Slide as Chips Lead and Yields Climb
      Health

      Weekly Gains Hold Up Despite a Friday Slide as Chips Lead and Yields Climb

      November 13, 2026
      Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
      Health

      Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth

      November 13, 2026
      Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Health

      Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      November 13, 2026
      The NYSE Welcomes vVARDIS as a Publicly Listed Company
      Health

      The NYSE Welcomes vVARDIS as a Publicly Listed Company

      November 13, 2026
      K-BRO DECLARES NOVEMBER 2026 DIVIDEND
      Health

      K-BRO DECLARES NOVEMBER 2026 DIVIDEND

      November 13, 2026
      Pasithea Therapeutics Presents Positive Initial Phase 1/1b Data for PAS-004, Showing Substantial Reductions in Cutaneous Neurofibroma Size and Early Activity in Plexiform Neurofibromas at the 2026 European Neurofibromatosis Conference
      Health

      Pasithea Therapeutics Presents Positive Initial Phase 1/1b Data for PAS-004, Showing Substantial Reductions in Cutaneous Neurofibroma Size and Early Activity in Plexiform Neurofibromas at the 2026 European Neurofibromatosis Conference

      November 13, 2026
      Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update
      Health

      Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update

      November 13, 2026
      Cipher Pharmaceuticals Reports Third Quarter 2026 Results
      Health

      Cipher Pharmaceuticals Reports Third Quarter 2026 Results

      November 12, 2026
      K-BRO REPORTS Q3 RESULTS AND POSITIVE OUTLOOK (TSX: KBL)
      Health

      K-BRO REPORTS Q3 RESULTS AND POSITIVE OUTLOOK (TSX: KBL)

      November 12, 2026
      « 1 2 3 4 5 6 … 277 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026